US contract development and manufacturing organisation (CDMO) Xcelience has opened its new 71,000ft2 headquarters in Tampa, Florida.
The building houses preformulation and formulation development laboratories and suites, as well as analytical and stability services. The official ribbon cutting ceremony was attended by Florida Governor Rick Scott, Tampa Mayor Bob Buckhorn and other officials.
The new building houses a newly-constructed, state-of-the art formulation lab, as well as the executive headquarters. Build out plans for a new analytical lab are also developing. The company's previous headquarters in Tampa will be transformed to provide clinical trial and small-scale commercial manufacturing.
'This year marks a rapid expansion in our service offerings,' said Derek Hennecke, President and CEO. 'In July we integrated with Powdersize because so many of our clients needed industry-leading micronisation services. Now, with this new facility, we will be able to increase capacity throughout the organisation. More capacity means we can be more flexible in dealing with changing client needs and timelines.'
Xcelience provides services from preformulation to global clinical supplies packaging and distribution to international pharmaceutical and biotechnology clients for Phases I–IV.
Since being established in 2006, Xcelience has grown from one facility with 45 employees to an international CDMO provider, with seven facilities and a staff of more than 200.
